We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
Raymond James Financial Inc. acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the fourth ...
StockStory.org on MSN6d
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics StocksAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - ...
Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and ...
Lantheus Holdings, Inc.'s stock soars 55%, fueled by Pylarify and strategic acquisitions in Alzheimer's and oncology. Click ...
Lantheus Holdings Inc (NASDAQ:LNTH) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 2024 revenue is $375.43 million, and the earnings are expected to come in at ...
Charles Schwab Investment Management Inc. cut its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the ...
Reports Q4 revenue $391.1M, consensus $376.18M. “2024 was a groundbreaking year for Lantheus (LNTH), as our radiodiagnostic, PYLARIFY, reached ...
Explore the exciting world of Lantheus Holdings (NASDAQ: LNTH) with our expert analysts in this Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results